Literature DB >> 25878345

Implementation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Routine Clinical Laboratories Improves Identification of Coagulase-Negative Staphylococci and Reveals the Pathogenic Role of Staphylococcus lugdunensis.

Xavier Argemi1, Philippe Riegel2, Thierry Lavigne3, Nicolas Lefebvre4, Nicolas Grandpré2, Yves Hansmann4, Benoit Jaulhac2, Gilles Prévost3, Frédéric Schramm2.   

Abstract

The use of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for staphylococcal identification is now considered routine in laboratories compared with the conventional phenotypical methods previously used. We verified its microbiological relevance for identifying the main species of coagulase-negative staphylococci (CoNS) by randomly selecting 50 isolates. From 1 January 2007 to 31 August 2008, 12,479 staphylococci were isolated with phenotypic methods, of which 4,594 were identified as Staphylococcus aureus and 7,885 were coagulase negative staphylococci. Using MALDI-TOF MS from 1 January 2011 to 31 August 2012, 14,913 staphylococci were identified, with 5,066 as S. aureus and 9,847 as CoNS. MALDI-TOF MS allowed the identification of approximately 85% of the CoNS strains, whereas only 14% of the CoNS strains were identified to the species level with phenotypic methods because they were often considered contaminants. Furthermore, the use of MALDI-TOF MS revealed the occurrence of recently characterized Staphylococcus species, such as S. pettenkoferi, S. condimenti, and S. piscifermentans. Microbiological relevance analysis further revealed that some species displayed a high rate of microbiological significance, i.e., 40% of the S. lugdunensis strains included in the analysis were associated with infection risk. This retrospective microbiological study confirms the role of MALDI-TOF MS in clinical settings for the identification of staphylococci with clinical consequences. The species distribution reveals the occurrence of the recently identified species S. pettenkoferi and putative virulent species, including S. lugdunensis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25878345      PMCID: PMC4473201          DOI: 10.1128/JCM.00177-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  First case of osteomyelitis caused by "Staphylococcus pettenkoferi".

Authors:  Caroline Loïez; Frédéric Wallet; Patricia Pischedda; Emilie Renaux; Eric Senneville; Nazim Mehdi; René J Courcol
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

2.  Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Piseth Seng; Michel Drancourt; Frédérique Gouriet; Bernard La Scola; Pierre-Edouard Fournier; Jean Marc Rolain; Didier Raoult
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

3.  Unbiased species-level identification of clinical isolates of coagulase-negative Staphylococci: does it change the perspective on Staphylococcus lugdunensis?

Authors:  Wael F Elamin; David Ball; Michael Millar
Journal:  J Clin Microbiol       Date:  2014-10-22       Impact factor: 5.948

4.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology.

Authors:  Robin Patel
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079

5.  When is coagulase-negative Staphylococcus bacteraemia clinically significant?

Authors:  Elisa García-Vázquez; Ana Fernández-Rufete; Alicia Hernández-Torres; Manuel Canteras; Joaquín Ruiz; Joaquín Gómez
Journal:  Scand J Infect Dis       Date:  2013-07-01

6.  First report of a left ventricular assist device infection caused by Staphylococcus schleiferi subspecies coagulans: a coagulase-positive organism.

Authors:  Evangeline Thibodeau; Helen Boucher; David Denofrio; Duc Thinh Pham; David Snydman
Journal:  Diagn Microbiol Infect Dis       Date:  2012-06-27       Impact factor: 2.803

7.  Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures.

Authors:  C Brun-Buisson; F Abrouk; P Legrand; Y Huet; S Larabi; M Rapin
Journal:  Arch Intern Med       Date:  1987-05

8.  Shunt-related intracranial abscess caused by Staphylococcus lugdunensis in a hydranencephalic patient.

Authors:  Yan Michael Li; Donald J Blaskiewicz; Walter A Hall
Journal:  World Neurosurg       Date:  2013-01-12       Impact factor: 2.104

9.  Role of coagulase-negative staphylococci in human disease.

Authors:  A Piette; G Verschraegen
Journal:  Vet Microbiol       Date:  2008-09-11       Impact factor: 3.293

10.  Quantitative culture of intravenous catheters and other intravascular inserts.

Authors:  D J Cleri; M L Corrado; S J Seligman
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

View more
  26 in total

1.  Epidemiology, Clinical Characteristics, and Antimicrobial Susceptibility Profiles of Human Clinical Isolates of Staphylococcus intermedius Group.

Authors:  Melanie L Yarbrough; William Lainhart; C A Burnham
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  Evaluation of Oxacillin and Cefoxitin Disk Diffusion and MIC Breakpoints Established by the Clinical and Laboratory Standards Institute for Detection of mecA-Mediated Oxacillin Resistance in Staphylococcus schleiferi.

Authors:  H K Huse; S A Miller; S Chandrasekaran; J A Hindler; S D Lawhon; D A Bemis; L F Westblade; R M Humphries
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

3.  Coagulase-negative staphylococci in outpatient routines: the implications of switching from CLSI to BrCAST/EUCAST guidelines.

Authors:  Vinícius Pietta Perez; Jéssica Karoliny Baptista Porto Carvalho; Marianne Schrader de Oliveira; Adriana Medianeira Rossato; Caroline Dani; Gertrudes Corção; Pedro Alves d'Azevedo
Journal:  Braz J Microbiol       Date:  2020-04-23       Impact factor: 2.476

Review 4.  Is Staphylococcus lugdunensis Significant in Clinical Samples?

Authors:  Xavier Argemi; Yves Hansmann; Philippe Riegel; Gilles Prévost
Journal:  J Clin Microbiol       Date:  2017-08-23       Impact factor: 5.948

5.  Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.

Authors:  Helio S Sader; Robert K Flamm; Rodrigo E Mendes; David J Farrell; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 6.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

7.  Genomic relatedness of Staphylococcus pettenkoferi isolates of different origins.

Authors:  Emeli Månsson; Bengt Hellmark; Marc Stegger; Paal Skytt Andersen; Martin Sundqvist; Bo Söderquist
Journal:  J Med Microbiol       Date:  2017-05       Impact factor: 2.472

8.  Whole-Genome Sequencing of Seven Strains of Staphylococcus lugdunensis Allows Identification of Mobile Genetic Elements.

Authors:  Xavier Argemi; Véronique Martin; Valentin Loux; Sandrine Dahyot; Jérémie Lebeurre; Aurélien Guffroy; Mickael Martin; Aurélie Velay; Daniel Keller; Philippe Riegel; Yves Hansmann; Nicodème Paul; Gilles Prévost
Journal:  Genome Biol Evol       Date:  2017-05-01       Impact factor: 3.416

Review 9.  Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential.

Authors:  Simon Heilbronner; Timothy J Foster
Journal:  Clin Microbiol Rev       Date:  2020-12-23       Impact factor: 26.132

10.  Complete Genome Sequence and Comparative Analysis of Staphylococcus condimenti DSM 11674, a Potential Starter Culture Isolated from Soy Sauce Mash.

Authors:  Huihui Dong; Jian Chen; Andrew K Hastings; Lihua Guo; Beiwen Zheng
Journal:  Front Bioeng Biotechnol       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.